Bridgewater Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.23M | Buy |
|
|||||
|
2025
Q2 | $1.12M | Sell |
|
|||||
|
2025
Q1 | $9.65M | Sell |
|
|||||
|
2024
Q4 | $45.4M | Buy |
|
|||||
|
2024
Q3 | $15.6M | Buy |
|
|||||
|
2024
Q2 | $12.1M | Buy |
|
|||||
|
2024
Q1 | $3.19M | Sell |
|
|||||
|
2023
Q4 | $3.1M | Sell |
|
|||||
|
2023
Q3 | $6.19M | Sell |
|
|||||
|
2023
Q2 | $5.2M | Sell |
|
|||||
|
2023
Q1 | $5.99M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $634K | Buy |
|
|||||
|
2022
Q1 | $471K | Buy |
|
|||||
|
2021
Q4 | $215K | Sell |
|
|||||
|
2021
Q3 | $307K | Sell |
|
|||||
|
2021
Q2 | $577K | Buy |
|